Suggestions based on these studies

Citations are updated once a week. Recently added citations may not appear.

Suggestions are not based on a simple count

The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.

**4 Citations Found,** *Full List Requires Login* Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
📓 - Direct Citation | 👪 - Infer Parent | 👶 - Infer Child | ⚗️ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction | 😢 - Shifts in wrong direction
Context	Citation
Decreases Pseudomonas aeruginosa BL10 - : tobramycin	👶 Combination treatment to improve mucociliary transport of Pseudomonas aeruginosa biofilms. PloS one (PLoS One ) Vol: 19 Issue 2 Pages: e0294120 Pub: 2024 Epub: 2024 Feb 23 Authors Rouillard KR , Esther CP , Kissner WJ , Plott LM , Bowman DW , Markovetz MR , Hill DB , Html Article Publication
Decreases Pseudomonas aeruginosa BL10 - : tobramycin	👶 New Recommendations of a Height-Based Dosing Regimen of Tobramycin for Cystic Fibrosis in Adults: A Population Pharmacokinetic Analysis. Therapeutic drug monitoring (Ther Drug Monit ) Vol: 45 Issue 2 Pages: 251-258 Pub: 2023 Apr 1 Epub: Authors Koloskoff K , Thirion DJG , Matouk E , Marsot A , Publication
Decreases Pseudomonas aeruginosa BL10 - : tobramycin	👶 Synergistic effect of the combination of phenolic compounds and tobramycin on the inhibition of Pseudomonas aeruginosa biofilm. Microbial pathogenesis (Microb Pathog ) Vol: Issue Pages: 107079 Pub: 2024 Oct 23 Epub: 2024 Oct 23 Authors Lima EMF , Bueris V , Germano LG , Sircili MP , Pinto UM , Publication
Decreases Pseudomonas aeruginosa BL10 - : tobramycin	👶 Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencing. International journal of antimicrobial agents (Int J Antimicrob Agents ) Vol: 63 Issue 6 Pages: 107161 Pub: 2024 Jun Epub: 2024 Mar 30 Authors Breen SKJ , Harper M , López-Causapé C , Rogers KE , Tait JR , Smallman TR , Lang Y , Lee WL , Zhou J , Zhang Y , Bulitta JB , Nation RL , Oliver A , Boyce JD , Landersdorfer CB , Publication
0 😁	😢 0

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]